Početna stranicaDSNKY • OTCMKTS
add
Daiichi Sankyo Co Ltd - ADR
Predvodnik u zaštiti okolišaZemlja u kojoj se trguje vrijednosnicom: SADZemlja u kojoj se nalazi sjedište: JPPreth. zaklj. cijena
32,86 $
Dnevni raspon
33,29 $ - 34,19 $
Godišnji raspon
23,72 $ - 42,48 $
Tržišna kapitalizacija
64,85 mlr. USD
Prosječna količina
71,02 tis.
Vijesti s tržišta
Financijski podaci
Račun dobiti i gubitka
Prihod
Neto dohodak
| (JPY) | lip 2024.info | Godišnja promjena |
|---|---|---|
Prihod | 436,18 mlr. | 24,32 % |
Operativni troškovi | 248,15 mlr. | 16,43 % |
Neto dohodak | 85,38 mlr. | 49,76 % |
Neto profitabilnost | 19,58 | 20,49 % |
Zarada po dionici | — | — |
EBITDA | 109,60 mlr. | 88,30 % |
Efektivna porezna stopa | 22,52 % | — |
Bilanca stanja
Ukupna imovina
Ukupne obveze
| (JPY) | lip 2024.info | Godišnja promjena |
|---|---|---|
Gotovinska i kratkoročna ulaganja | 805,26 mlr. | 54,96 % |
Ukupna imovina | 3,44 bil. | 31,39 % |
Ukupne obveze | 1,72 bil. | 58,01 % |
Ukupni kapital | 1,72 bil. | — |
Dionice u optjecaju | 1,91 mlr. | — |
Cijena prema knjigovodstvenoj vrijednosti | 0,04 | — |
Povrat imovine | 6,74 % | — |
Povrat kapitala | 12,87 % | — |
Tok novca
Neto promjena novca
| (JPY) | lip 2024.info | Godišnja promjena |
|---|---|---|
Neto dohodak | 85,38 mlr. | 49,76 % |
Gotovina od poslovanja | −110,04 mlr. | −137,99 % |
Gotovina iz ulaganja | 357,30 mlr. | 154,50 % |
Gotovina iz financiranja | −107,56 mlr. | −230,66 % |
Neto promjena novca | 158,08 mlr. | 103,34 % |
Slobodan tok novca | 251,00 mlr. | 158,90 % |
Više
Daiichi Sankyo Company, Limited is a global pharmaceutical company and the second-largest pharmaceutical company in Japan. It achieved JPY 1,278 billion in revenue in 2022. The company owns the American pharmaceutical company American Regent.
Daiichi Sankyo, Inc. began operating in the U.S. in 2006. It is the U.S. subsidiary of Daiichi Sankyo Company, Limited, and a member of the Daiichi Sankyo Group. The organization, which includes U.S. commercial operations and global clinical development, is headquartered in Basking Ridge, New Jersey.
Daiichi Sankyo Europe, GmbH, the European subsidiary, is headquartered in Munich, Germany. The organization is responsible for development and manufacturing for 12 European countries.
Daiichi Sankyo Company, Limited is a full member of the European Federation of Pharmaceutical Industries and Associations and of the International Federation of Pharmaceutical Manufacturers and Associations. Wikipedia
Glavni izvršni direktor
Osnovano
28. ruj 2005.
Sjedište
Web-lokacija
Zaposlenici
18.726
